Accordingly, over the same concentration range that inhibited LSD1 activity in vitro, oleacein treatment efficiently blocked the re-activation of SOX2 that is known to be controlled by the binding of LSD1 to the SOX2 distal enhancer differentially occurring in tumor cells with CSC-like properties. The gene discussed is SOX2; the disease is neoplasm.